Option chain shows key data for Oculis Holding's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Oculis Holding.

Oculis Holding (NASDAQ:OCS) Stock, Option Chain

Oculis Holding

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Munich,,Bavaria,,Germany,-,March,31,2023:,Dave,Inc.,Is

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

CARG

CVRX

DAVE

DPRO

IOVA

MKSI

VITL

Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday

West,Bangal,,India,-,April,20,,2022,:,Intuit,Logo

ADVM

COIN

GNRC

INTU

TTAN

Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

movers image

Intraday Update

Movers

MRUS

MVST

PCRX

RPRX

TALO

TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday

Oculis Holding AG

Oaktree Specialty Lending Corporation - Closed End Fund

Oaktree Specialty Lending Corp

Health Care

Press Releases

Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond

General

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets

Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award

Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences

Oculis to Present at Upcoming May Investor Conferences

Earnings

Oculis Reports Q1 2025 Financial Results and Provides Company Update

Oculis Publishes Invitation to the Annual General Meeting

Oculis to Participate in Upcoming June Investor Conferences

Management

Oculis Publishes Results of 2025 Annual General Meeting

Chardan Capital

HC Wainwright & Co.

Baird

B of A Securities

Wedbush

Comments

Oculis Holding

Oculis Holding (OCS) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell